Alliance Wealth Advisors LLC UT grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 1.3% in the 4th quarter, HoldingsChannel reports. The firm owned 5,495 shares of the healthcare conglomerate’s stock after acquiring an additional 69 shares during the quarter. UnitedHealth Group makes up about 1.0% of Alliance Wealth Advisors LLC UT’s portfolio, making the stock its 28th biggest position. Alliance Wealth Advisors LLC UT’s holdings in UnitedHealth Group were worth $2,893,000 at the end of the most recent reporting period.
Several other hedge funds have also modified their holdings of the stock. Richelieu Gestion SA purchased a new stake in UnitedHealth Group in the 4th quarter worth about $26,000. Robbins Farley acquired a new position in UnitedHealth Group in the 3rd quarter worth about $25,000. CGC Financial Services LLC increased its position in UnitedHealth Group by 1,000.0% in the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 50 shares during the last quarter. NewSquare Capital LLC increased its position in UnitedHealth Group by 340.0% in the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after purchasing an additional 51 shares during the last quarter. Finally, LFA Lugano Financial Advisors SA increased its holdings in shares of UnitedHealth Group by 148.1% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after acquiring an additional 40 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.
UnitedHealth Group Price Performance
UNH stock traded up $1.49 during trading on Friday, hitting $495.35. The company had a trading volume of 2,727,016 shares, compared to its average volume of 5,623,667. The company has a current ratio of 0.85, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69. The company has a market cap of $455.76 billion, a P/E ratio of 30.28, a P/E/G ratio of 1.43 and a beta of 0.54. The company has a fifty day moving average price of $485.84 and a two-hundred day moving average price of $514.21. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $554.70.
UnitedHealth Group Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were paid a dividend of $1.88 per share. This represents a $7.52 annualized dividend and a dividend yield of 1.52%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 45.97%.
Analyst Ratings Changes
A number of brokerages have recently commented on UNH. Deutsche Bank Aktiengesellschaft increased their price objective on UnitedHealth Group from $545.00 to $562.00 and gave the company a “buy” rating in a report on Friday, April 19th. Stephens reaffirmed an “overweight” rating and issued a $605.00 price target on shares of UnitedHealth Group in a research report on Thursday, February 8th. Piper Sandler lifted their price target on UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 17th. Wells Fargo & Company dropped their price target on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a research report on Monday, April 8th. Finally, Truist Financial reaffirmed a “buy” rating and issued a $600.00 price target on shares of UnitedHealth Group in a research report on Wednesday, April 17th. Four analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $570.05.
Read Our Latest Stock Report on UnitedHealth Group
Insider Activity
In related news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Thomas E. Roos sold 858 shares of the stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by insiders.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More
- Five stocks we like better than UnitedHealth Group
- High Flyers: 3 Natural Gas Stocks for March 2022
- MarketBeat Week in Review – 4/22 – 4/26
- Insider Trades May Not Tell You What You Think
- 3 Stocks Leading the U.S. Agriculture Comeback
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- How to Use Put Debit Spreads to Profit From Falling Stocks
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.